Identification of construction and biological characters of tongue carcinoma cell line T-TFL

刘大庆,司徒镇强,曹云新,于翠娟,王成济,杨安钢

DOI: https://doi.org/10.3321/j.issn:1673-8225.2004.11.054

2004-01-01

Abstract:BACKGROUND: The application of gene therapy has brought new hopes to the cure of cancer, but there were still few reports on tongue carcinoma gene therapy.OBJECTIVE: To construct the fusion gene TFL including the partial domains of Fas-associated death domain protein(FADD) and tumor necrosis factor receptor 1 (TNFR1) gene, then transfected it into human tongue squamous carcinoma cell line(Tca-8113) to construct and identify the cell line T-TFL which contained the fusion gene TFL in order to establish a means of improving the tongue carcinoma patients. To explore a therapeutic means in favour of the tongue carcinoma patient' s survival quality.DESIGN: A prospective study was performed according to the diagnosis.SETTING and PARTICIPANTS: The experiment was completed in Department of Oral and Maxillofacial Surgery, College of Stomatology, Fourth Military Medical University. The subject was human tongue squamous carcinoma cell line Tca-8113 established by College of Stomatology, Shanghai Second Medical Uniersity.INTERVENTIONS: RT-PCR was used to obtain cDNA of human FADD and TNFR1 gene. and recombinant PCR was used to construct TFL fusion gene;then transfected the fusion gene into Tca-8113 cells stabilized by plasmid-liposome complex transduction method.MAIN OUTCOME MEASURES: The fusion protein TNFR1/DED expression was detected by western blot; the morphological obervation and growth curve assay were used to evaluate the biological characters of T-TFL cell.RESULTS: Human FADD and TNFR1 gene were obtained respectively, the fusion gene TFL was constructed successfully. The T-TFL cell could expressed the fusion protein TNFR1/DED after TFL gene was transfected into it, and there were no obvious differences in biological characters between T-TFL and Tca-8113 cells.CONCLUSION: The construction of the fusion gene TFL and the T-TFL cell line could express the fusion protein TNFR1/DED, which could afford a novel experimental basis for human tongue carcinoma gene therapy.